Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2018. Module: SNOMED CT core
Descriptions:
Id | Description | Lang | Type | Status | Case? | Module |
3692832010 | Product containing precisely betamethasone sodium phosphate 1 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release eye ointment (clinical drug) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
3692834011 | Betamethasone sodium phosphate 1 mg/g and neomycin sulfate 5 mg/g eye ointment | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
4533441000052115 | betametasonnatriumfosfat 1 milligram/gram och neomycinsulfat 5 milligram/gram, ögonsalva | sv | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT Sweden NRC maintained module (core metadata concept) |
Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
Product containing precisely betamethasone sodium phosphate 1 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release eye ointment (clinical drug) | Is a | Betamethasone+neomycin sulfate | false | Inferred relationship | Some | ||
Product containing precisely betamethasone sodium phosphate 1 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release eye ointment (clinical drug) | Is a | Miscellaneous eye preparations | false | Inferred relationship | Some | ||
Product containing precisely betamethasone sodium phosphate 1 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release eye ointment (clinical drug) | Has active ingredient | Betamethasone | false | Inferred relationship | Some | ||
Product containing precisely betamethasone sodium phosphate 1 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release eye ointment (clinical drug) | Has active ingredient | Adrenal hormone | false | Inferred relationship | Some | ||
Product containing precisely betamethasone sodium phosphate 1 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release eye ointment (clinical drug) | Is a | neomycin för lokalt bruk | false | Inferred relationship | Some | ||
Product containing precisely betamethasone sodium phosphate 1 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release eye ointment (clinical drug) | Is a | betametason för lokalt bruk | false | Inferred relationship | Some | ||
Product containing precisely betamethasone sodium phosphate 1 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release eye ointment (clinical drug) | Has active ingredient | Betamethasone sodium phosphate | false | Inferred relationship | Some | ||
Product containing precisely betamethasone sodium phosphate 1 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release eye ointment (clinical drug) | Has active ingredient | Corticosterone | false | Inferred relationship | Some | ||
Product containing precisely betamethasone sodium phosphate 1 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release eye ointment (clinical drug) | Has active ingredient | Neomycin sulfate | false | Inferred relationship | Some | ||
Product containing precisely betamethasone sodium phosphate 1 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release eye ointment (clinical drug) | Has active ingredient | antiinfektivt medel för huden | false | Inferred relationship | Some | ||
Product containing precisely betamethasone sodium phosphate 1 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release eye ointment (clinical drug) | Has active ingredient | binjurehormonmedel | false | Inferred relationship | Some | ||
Product containing precisely betamethasone sodium phosphate 1 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release eye ointment (clinical drug) | Has active ingredient | Glucocorticoid hormone | false | Inferred relationship | Some | ||
Product containing precisely betamethasone sodium phosphate 1 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release eye ointment (clinical drug) | Has active ingredient | Bactericide | false | Inferred relationship | Some | ||
Product containing precisely betamethasone sodium phosphate 1 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release eye ointment (clinical drug) | Has active ingredient | Local anti-infective | false | Inferred relationship | Some | ||
Product containing precisely betamethasone sodium phosphate 1 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release eye ointment (clinical drug) | Is a | betametason för oftalmiskt bruk | false | Inferred relationship | Some | ||
Product containing precisely betamethasone sodium phosphate 1 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release eye ointment (clinical drug) | Is a | neomycin för oftalmiskt bruk | false | Inferred relationship | Some | ||
Product containing precisely betamethasone sodium phosphate 1 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release eye ointment (clinical drug) | Has manufactured dose form | Ocular dose form (dose form) | false | Inferred relationship | Some | ||
Product containing precisely betamethasone sodium phosphate 1 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release eye ointment (clinical drug) | Has manufactured dose form | Eye ointment | true | Inferred relationship | Some | ||
Product containing precisely betamethasone sodium phosphate 1 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release eye ointment (clinical drug) | Is a | Product containing betamethasone and neomycin (medicinal product) | false | Inferred relationship | Some | ||
Product containing precisely betamethasone sodium phosphate 1 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release eye ointment (clinical drug) | räkning av bas i aktiv ingrediens | två | false | Inferred relationship | Some | ||
Product containing precisely betamethasone sodium phosphate 1 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release eye ointment (clinical drug) | har täljarvärde för koncentrationsstyrka | fem | false | Inferred relationship | Some | 2 | |
Product containing precisely betamethasone sodium phosphate 1 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release eye ointment (clinical drug) | har täljarvärde för koncentrationsstyrka | ett | false | Inferred relationship | Some | 1 | |
Product containing precisely betamethasone sodium phosphate 1 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release eye ointment (clinical drug) | Has precise active ingredient | Betamethasone sodium phosphate | true | Inferred relationship | Some | 1 | |
Product containing precisely betamethasone sodium phosphate 1 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release eye ointment (clinical drug) | Has precise active ingredient | Neomycin sulfate | true | Inferred relationship | Some | 2 | |
Product containing precisely betamethasone sodium phosphate 1 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release eye ointment (clinical drug) | Has concentration strength denominator unit | g | true | Inferred relationship | Some | 2 | |
Product containing precisely betamethasone sodium phosphate 1 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release eye ointment (clinical drug) | Has basis of strength substance (attribute) | Betamethasone sodium phosphate | true | Inferred relationship | Some | 1 | |
Product containing precisely betamethasone sodium phosphate 1 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release eye ointment (clinical drug) | Has concentration strength numerator unit | mg | true | Inferred relationship | Some | 2 | |
Product containing precisely betamethasone sodium phosphate 1 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release eye ointment (clinical drug) | har nämnarvärde som visar koncentrationsstyrka | ett | false | Inferred relationship | Some | 2 | |
Product containing precisely betamethasone sodium phosphate 1 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release eye ointment (clinical drug) | Has basis of strength substance (attribute) | Neomycin sulfate | true | Inferred relationship | Some | 2 | |
Product containing precisely betamethasone sodium phosphate 1 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release eye ointment (clinical drug) | Has concentration strength numerator unit | mg | true | Inferred relationship | Some | 1 | |
Product containing precisely betamethasone sodium phosphate 1 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release eye ointment (clinical drug) | har nämnarvärde som visar koncentrationsstyrka | ett | false | Inferred relationship | Some | 1 | |
Product containing precisely betamethasone sodium phosphate 1 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release eye ointment (clinical drug) | Has concentration strength denominator unit | g | true | Inferred relationship | Some | 1 | |
Product containing precisely betamethasone sodium phosphate 1 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release eye ointment (clinical drug) | Is a | Product containing only betamethasone and neomycin in ocular dose form (medicinal product form) | true | Inferred relationship | Some | ||
Product containing precisely betamethasone sodium phosphate 1 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release eye ointment (clinical drug) | Plays role | Antibacterial therapeutic role (role) | true | Inferred relationship | Some | ||
Product containing precisely betamethasone sodium phosphate 1 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release eye ointment (clinical drug) | Is a | Product containing glucocorticoid (product) | false | Inferred relationship | Some | ||
Product containing precisely betamethasone sodium phosphate 1 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release eye ointment (clinical drug) | Is a | Product containing aminoglycoside (product) | false | Inferred relationship | Some | ||
Product containing precisely betamethasone sodium phosphate 1 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release eye ointment (clinical drug) | Is a | Medicinal product acting as antibacterial agent (product) | false | Inferred relationship | Some | ||
Product containing precisely betamethasone sodium phosphate 1 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release eye ointment (clinical drug) | Is a | Product manufactured as ocular dose form (product) | false | Inferred relationship | Some | ||
Product containing precisely betamethasone sodium phosphate 1 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release eye ointment (clinical drug) | Is a | Product containing fluorinated corticosteroid (product) | false | Inferred relationship | Some | ||
Product containing precisely betamethasone sodium phosphate 1 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release eye ointment (clinical drug) | Is a | Product containing pregnane (product) | false | Inferred relationship | Some |
Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Reference Sets